Ozempic, Wegovy Among 15 Drugs Selected by HHS for Medicare Price Negotiations

By Katabella Roberts The U.S. Department of Health and Human Services (HHS) said on Jan. 17 that it has selected the next 15 drugs to undergo Medicare drug price negotiations with pharmaceutical companies, as the federal government seeks to lower soaring medical costs for Americans. The drugs are relied upon by millions of seniors across the country to treat an array of conditions such…

Source

Leave a Reply

Your email address will not be published.

Previous post Teri Loxam Sells 6,250 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) Stock
Next post Short Interest in Gibraltar Industries, Inc. (NASDAQ:ROCK) Drops By 27.8%